| In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens |
95 |
| Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial |
63 |
| Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections |
23 |
| Infectious Disease Management and Control with Povidone Iodine |
23 |
| Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation |
16 |
| Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children |
16 |
| Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties |
13 |
| A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population |
12 |
| The Epidemiology of Clostridium difficile Infection in Japan: A Systematic Review |
10 |
| Bactericidal and Virucidal Activity of Povidone-Iodine and Chlorhexidine Gluconate Cleansers in an In Vivo Hand Hygiene Clinical Simulation Study |
10 |
| Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review |
9 |
| Challenges and Solution of Invasive Aspergillosis in Non-neutropenic Patients: A Review |
9 |
| A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing? |
9 |
| Clostridium difficile-associated Diarrhea in Developing Countries: A Systematic Review and Meta-Analysis |
9 |
| Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers |
9 |
| Immunological and Clinical Benefits of Maternal Immunization Against Pertussis: A Systematic Review |
7 |
| Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada |
6 |
| Epidemiologic Trends, Global Shifts in Meningococcal Vaccination Guidelines, and Data Supporting the Use of MenACWY-TT Vaccine: A Review |
5 |
| Safety, Resistance, and Efficacy Results from a Phase IIIb Study of Conventional- and Double-Dose Oseltamivir Regimens for Treatment of Influenza in Immunocompromised Patients |
5 |
| An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa |
5 |
| Incidence and Prevention of Invasive Meningococcal Disease in Global Mass Gathering Events |
5 |
| Geographic Variability in Diagnosis and Antibiotic Prescribing for Acute Respiratory Tract Infections |
4 |
| Post-Obstructive Pneumonia in Patients with Cancer: A Review |
4 |
| Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus? |
4 |
| Teaching an Old Class New Tricks: A Novel Semi-Synthetic Aminoglycoside, Plazomicin |
4 |
| Safety of Maternal Immunization Against Pertussis: A Systematic Review |
4 |
| Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis? |
4 |
| Increasing Burden of Hepatitis A in Adolescents and Adults and the Need for Long-Term Protection: A Review from the Indian Subcontinent |
3 |
| Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007) |
3 |
| Passive Screening and Diagnosis of Sleeping Sickness with New Tools in Primary Health Services: An Operational Research |
3 |
| Safety of Probiotics Among High-Risk Pediatric Hematopoietic Stem Cell Transplant Recipients |
3 |
| HIV, HCV and HBV: A Review of Parallels and Differences |
3 |
| Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study |
3 |
| Negative IgG Varicella Zoster Virus Antibody Status: Immune Responses Pre and Post Re-immunization |
3 |
| Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series |
3 |
| Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality |
2 |
| Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study |
2 |
| The Impact of Hepatitis C Virus Direct-Acting Antivirals on Patient-Reported Outcomes: A Dutch Prospective Cohort Study |
2 |
| Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis |
2 |
| Microbial Epidemiology of Infectious Endocarditis in the Intravenous Drug Abuse Population: A Retrospective Study |
2 |
| A Markov Model to Estimate Mortality Due to HIV/AIDS Using Viral Load Levels-Based States and CD4 Cell Counts: A Principal Component Analysis Approach |
2 |
| Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials |
2 |
| Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials |
2 |
| Neonatal Pertussis, an Under-Recognized Health Burden and Rationale for Maternal Immunization: A Systematic Review of South and South-East Asian Countries |
2 |
| Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus |
2 |
| Burden of Co-Infection: A Cost Analysis of Human Immunodeficiency Virus in a Commercially Insured Hepatitis C Virus Population |
2 |
| The Clinical and Molecular Epidemiology of CTX-M-9 Group Producing Enterobacteriaceae Infections in Children |
2 |
| Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study |
2 |
| Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine When Co-Administered with Tetanus-Reduced Diphtheria-Acellular Pertussis and Quadrivalent Meningococcal Conjugate Vaccines in Healthy Adolescents: Results from a Randomized, Observer-Blind, Controlled Trial |
2 |
| Clinical Features of Bloodstream Infections Associated with Peripheral Versus Central Venous Catheters |
2 |
